Fingerprint
Dive into the research topics of 'Phase Ib/II study of the safety and efficacy of combination therapy with multikinase VEGF inhibitor pazopanib and MEK inhibitor trametinib in advanced soft tissue sarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically